FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3158038178> ?p ?o ?g. }

• W3158038178 endingPage "S5" @default.
• W3158038178 startingPage "S5" @default.
• W3158038178 abstract "The purpose of this study was to evaluate the safety, efficacy, and survival following radioembolization (Y90) for unresectable intrahepatic cholangiocarcinoma (ICC). Our hypothesis was Y90 would provide high antitumor response with a tolerable safety profile. An IRB-approved retrospective analysis was performed in 138 consecutive patients with ICC treated with Y90 from 2004 to 2020. Primary outcomes were clinical and biochemical toxicities by CTCAE (version 5.0) and tumor response by World Health Organizing (WHO) criteria. Secondary outcomes were time-to-progression (TTP) and overall survival (OS) by the Kaplan-Meier method with censoring to resection/transplantation. Univariate and multivariate survival analyses were performed with log-rank tests and Cox proportional-hazards model, respectively. Baseline characteristics included solitary tumor in 56 (40.6%), unilobar distribution in 59 (42.8%), tumor burden < 25% in 96 (69.6%), extrahepatic disease in 48 (34.8%), and prior chemotherapy in 56 (40.6%). Grade 3+ clinical toxicities occurred in 10 (7.5%). Grade 3 bilirubin and alkaline phosphatase toxicities occurred in 4 (3.2%) and 2 (1.6%), respectively. Best response rates (WHO) were complete response in 3 (2.3%), partial response in 46 (34.9%), stable disease in 74 (56.1%), and progressive disease in 9 (6.8%) patients. Median index lesion TTP was not reached. Median intrahepatic TTP and extrahepatic TTP were 5.9 months (95% CI, 4.1-8.4) and 13.1 months (95% CI, 7.4-19.6), respectively. Eleven patients (8.0%) were downstaged to resection with OS of 41.8 months (95% CI, 16.1-NE). Additionally, three patients (2.2%) were transplanted. Median time to recurrence was 26.6 months (95% CI, 4.4-NE). Median OS for the entire cohort was 13.8 months (95% CI, 10.5-16.0). On multivariate OS analysis, solitary ICC (P< 0.001), no prior chemotherapy (P = 0.02), tumor burden < 50% (P = 0.03), no tumor thrombus (P = 0.004), and higher serum albumin (P = 0.01) were positive prognosticators. Y90 has an acceptable safety profile in a large cohort of patients with heterogenous treatment history and disease burden. High local disease control rates and downstaging in select patients supports the therapeutic role of Y90 for unresectable ICC." @default.
• W3158038178 created "2021-05-10" @default.
• W3158038178 creator A5011003738 @default.
• W3158038178 creator A5033464248 @default.
• W3158038178 creator A5034975837 @default.
• W3158038178 creator A5037243800 @default.
• W3158038178 creator A5060796651 @default.
• W3158038178 creator A5075153200 @default.
• W3158038178 creator A5081349562 @default.
• W3158038178 creator A5090043054 @default.
• W3158038178 creator A5090639130 @default.
• W3158038178 date "2021-05-01" @default.
• W3158038178 modified "2023-10-14" @default.
• W3158038178 title "Abstract No. 8 Yttrium-90 radioembolization in unresectable intrahepatic cholangiocarcinoma: a 17-year single-institution study" @default.
• W3158038178 doi "https://doi.org/10.1016/j.jvir.2021.03.419" @default.
• W3158038178 hasPublicationYear "2021" @default.
• W3158038178 type Work @default.
• W3158038178 sameAs 3158038178 @default.
• W3158038178 citedByCount "0" @default.
• W3158038178 crossrefType "journal-article" @default.
• W3158038178 hasAuthorship W3158038178A5011003738 @default.
• W3158038178 hasAuthorship W3158038178A5033464248 @default.
• W3158038178 hasAuthorship W3158038178A5034975837 @default.
• W3158038178 hasAuthorship W3158038178A5037243800 @default.
• W3158038178 hasAuthorship W3158038178A5060796651 @default.
• W3158038178 hasAuthorship W3158038178A5075153200 @default.
• W3158038178 hasAuthorship W3158038178A5081349562 @default.
• W3158038178 hasAuthorship W3158038178A5090043054 @default.
• W3158038178 hasAuthorship W3158038178A5090639130 @default.
• W3158038178 hasBestOaLocation W31580381781 @default.
• W3158038178 hasConcept C10515644 @default.
• W3158038178 hasConcept C126322002 @default.
• W3158038178 hasConcept C141071460 @default.
• W3158038178 hasConcept C143998085 @default.
• W3158038178 hasConcept C144301174 @default.
• W3158038178 hasConcept C2776694085 @default.
• W3158038178 hasConcept C2778822529 @default.
• W3158038178 hasConcept C2909135397 @default.
• W3158038178 hasConcept C38180746 @default.
• W3158038178 hasConcept C50382708 @default.
• W3158038178 hasConcept C71924100 @default.
• W3158038178 hasConcept C90924648 @default.
• W3158038178 hasConceptScore W3158038178C10515644 @default.
• W3158038178 hasConceptScore W3158038178C126322002 @default.
• W3158038178 hasConceptScore W3158038178C141071460 @default.
• W3158038178 hasConceptScore W3158038178C143998085 @default.
• W3158038178 hasConceptScore W3158038178C144301174 @default.
• W3158038178 hasConceptScore W3158038178C2776694085 @default.
• W3158038178 hasConceptScore W3158038178C2778822529 @default.
• W3158038178 hasConceptScore W3158038178C2909135397 @default.
• W3158038178 hasConceptScore W3158038178C38180746 @default.
• W3158038178 hasConceptScore W3158038178C50382708 @default.
• W3158038178 hasConceptScore W3158038178C71924100 @default.
• W3158038178 hasConceptScore W3158038178C90924648 @default.
• W3158038178 hasIssue "5" @default.
• W3158038178 hasLocation W31580381781 @default.
• W3158038178 hasOpenAccess W3158038178 @default.
• W3158038178 hasPrimaryLocation W31580381781 @default.
• W3158038178 hasRelatedWork W1998259048 @default.
• W3158038178 hasRelatedWork W2164094466 @default.
• W3158038178 hasRelatedWork W2361700749 @default.
• W3158038178 hasRelatedWork W2381345080 @default.
• W3158038178 hasRelatedWork W2996950820 @default.
• W3158038178 hasRelatedWork W3028659695 @default.
• W3158038178 hasRelatedWork W3029118181 @default.
• W3158038178 hasRelatedWork W3032244995 @default.
• W3158038178 hasRelatedWork W4255845609 @default.
• W3158038178 hasRelatedWork W4361918880 @default.
• W3158038178 hasVolume "32" @default.
• W3158038178 isParatext "false" @default.
• W3158038178 isRetracted "false" @default.
• W3158038178 magId "3158038178" @default.
• W3158038178 workType "article" @default.